Scott Tran
Boehringer Ingelheim
Scott has been a scientist in upstream development at Boehringer Ingelheim for the last 3 years, working in areas related to late-stage development, data science, and scale-down model qualification. Born and raised in Los Angeles, he received his master’s in Bioprocess Engineering from UC Berkeley in 2021 following his Chemical Engineering studies at UC San Diego. His hobbies include playing tennis and traveling.
Appearances
DateJune 18, 2024End-to-end digital twins describe the entire manufacturing process with all relevant unit operations. They enable predictions of process parameter influence of any process step on critical quality attributes on drug substance level…Speaker
Boehringer Ingelheim
DateJune 18, 2024During these roundtables, experts will explore the benefits and challenges for implementation and highlight the "WHY" for using these respective technologies in the pharmaceutical industry: Model validation & verification, Accelerating Product and Model Life Cycle from Process Characterization unt…Speakers
Digital Enablement of Clinical Bioprocessing, GSKBoehringer IngelheimChristoph Herwig, PhDSenior Scientific Advisor, Körber Pharma AustriaExecutive Vice President - Partner, PQE Group
DateJune 18, 2024Speakers
Digital Enablement of Clinical Bioprocessing, GSKBoehringer IngelheimChristoph Herwig, PhDSenior Scientific Advisor, Körber Pharma AustriaExecutive Vice President - Partner, PQE Group
